Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$856K Sell
25,920
-4,080
-14% -$130K 0.22% 14
2014
Q4
$887K Buy
30,000
+2,420
+9% +$69.4K 0.22% 15
2014
Q3
$774K Buy
27,580
+1,984
+8% +$55.7K 0.19% 14
2014
Q2
$721K Buy
25,596
+9,289
+57% +$265K 0.17% 17
2014
Q1
$497K Buy
16,307
+44
+0.3% +$1.31K 0.1% 28
2013
Q4
$473K Hold
16,263
0.08% 31
2013
Q3
$443K Buy
16,263
+1,179
+8% +$32.1K 0.07% 29
2013
Q2
$401K Buy
+15,084
New +$417K 0.06% 35

Other funds holding PFE

MDE Group's PFE Position: Q1 2015 in Review

MDE Group reduced its Pfizer (PFE) stake by 14% in Q1 2015, selling an estimated $130K and leaving 25,920 shares worth $856K. The position accounts for 0.22% of the portfolio, ranked #14.

MDE Group first reported a position in PFE in Q2 2013 and has held it in 8 quarters since. The position peaked at $887K in Q4 2014. 1,876 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

  • MDE Group held 25,920 shares of Pfizer worth $856K as of Q1 2015.
  • MDE Group sold 4,080 Pfizer shares in Q1 2015, an estimated $130K.
  • Pfizer made up 0.22% of MDE Group's portfolio in Q1 2015, its #14 holding.
  • MDE Group first reported a position in Pfizer in Q2 2013 and has held it in 8 quarters since.
  • MDE Group's Pfizer position peaked at $887K in Q4 2014.
  • 1,876 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on MDE Group's 13F filing for Q1 2015, filed 22 Apr 2015.